{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:01:16Z","timestamp":1786546876309,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Bipolar Disord"],"DOI":"10.1186\/s40345-026-00429-7","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:38:35Z","timestamp":1780684715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thyroid hormone augmentation for bipolar disorder: a neurobiological and clinical narrative review"],"prefix":"10.1186","volume":"14","author":[{"given":"Muhammad","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair F.","family":"Bhutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Yassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rif S.","family":"El-Mallakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"5","key":"429_CR73","doi-asserted-by":"publisher","first-page":"e39712","DOI":"10.7759\/cureus.39712","volume":"15","author":"P Alhyan","year":"2023","unstructured":"Alhyan P, Aggarwal A, Chhillar N, Sharma S, Narang M, Malhotra RK. Effect of Valproate Monotherapy on Thyroid Function Tests and Magnesium Levels in Children With Epilepsy. Cureus. 2023;15(5):e39712. https:\/\/doi.org\/10.7759\/cureus.39712.","journal-title":"Cureus"},{"issue":"19","key":"429_CR18","doi-asserted-by":"publisher","first-page":"13733","DOI":"10.1016\/S0021-9258(17)36705-4","volume":"269","author":"A Allgeier","year":"1994","unstructured":"Allgeier A, Offermanns S, Van Sande J, Spicher K, Schultz G, Dumont JE. The human thyrotropin receptor activates G-proteins Gs and Gq\/11. J Biol Chem. 1994;269(19):13733\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/8188646\/.","journal-title":"J Biol Chem"},{"issue":"1","key":"429_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jcp.22325","volume":"226","author":"F Axelband","year":"2011","unstructured":"Axelband F, Dias J, Ferr\u00e3o FM, Einicker-Lamas M. Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system. J Cell Physiol. 2011;226(1):21\u20138. https:\/\/doi.org\/10.1002\/jcp.22325.","journal-title":"J Cell Physiol"},{"issue":"5","key":"429_CR59","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archpsyc.1990.01810170035006","volume":"47","author":"MS Bauer","year":"1990","unstructured":"Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry. 1990;47(5):435\u201340. https:\/\/doi.org\/10.1001\/archpsyc.1990.01810170035006.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"429_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/archpsyc.1990.01810170027005","volume":"47","author":"MS Bauer","year":"1990","unstructured":"Bauer MS, Whybrow PC, Winokur A. Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch Gen Psychiatry. 1990;47(5):427\u201332. https:\/\/doi.org\/10.1001\/archpsyc.1990.01810170027005.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"429_CR60","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0893-133X(97)00181-4","volume":"18","author":"M Bauer","year":"1998","unstructured":"Bauer M, Hellweg R, Gr\u00e4f KJ, Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol. 1998;18(6):444\u201355. https:\/\/doi.org\/10.1016\/S0893-133X(97)00181-4.","journal-title":"Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol"},{"issue":"4","key":"429_CR58","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0893-133X(02)00320-2","volume":"27","author":"M Bauer","year":"2002","unstructured":"Bauer M, Bergh\u00f6fer A, Bschor T, Baumgartner A, Kiesslinger U, Hellweg R, Adli M, Baethge C, M\u00fcller-Oerlinghausen B. Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol. 2002a;27(4):620\u20138. https:\/\/doi.org\/10.1016\/S0893-133X(02)00320-2.","journal-title":"Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol"},{"issue":"2\u20133","key":"429_CR85","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0165-0327(00)00363-3","volume":"68","author":"M Bauer","year":"2002","unstructured":"Bauer M, Baur H, Bergh\u00f6fer A, Str\u00f6hle A, Hellweg R, M\u00fcller-Oerlinghausen B, Baumgartner A. Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders. J Affect Disord. 2002b;68(2\u20133):285\u201394. https:\/\/doi.org\/10.1016\/s0165-0327(00)00363-3.","journal-title":"J Affect Disord"},{"issue":"5","key":"429_CR64","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/sj.mp.4001647","volume":"10","author":"M Bauer","year":"2005","unstructured":"Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler LL, Mandelkern MA, Bramen J, Voytek B, Woods R, Mazziotta JC, Whybrow PC. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry. 2005;10(5):456\u201369. https:\/\/doi.org\/10.1038\/sj.mp.4001647.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"429_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1365-2826.2008.01774.x","volume":"20","author":"M Bauer","year":"2008","unstructured":"Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008;20(10):1101\u201314. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01774.x.","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"429_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/mp.2014.186","volume":"21","author":"M Bauer","year":"2016","unstructured":"Bauer M, Berman S, Stamm T, Plotkin M, Adli M, Pilhatsch M, London ED, Hellemann GS, Whybrow PC, Schlagenhauf F. Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study. Mol Psychiatry. 2016;21(2):229\u201336. https:\/\/doi.org\/10.1038\/mp.2014.186.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"429_CR48","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archpsyc.1985.01790280019002","volume":"42","author":"LR Baxter Jr","year":"1985","unstructured":"Baxter LR Jr, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry. 1985;42(5):441\u20137. https:\/\/doi.org\/10.1001\/archpsyc.1985.01790280019002.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"429_CR24","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1210\/en.2005-0102","volume":"146","author":"JJ Bergh","year":"2005","unstructured":"Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005;146(7):2864\u201371. https:\/\/doi.org\/10.1210\/en.2005-0102.","journal-title":"Endocrinology"},{"key":"429_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jpsychires.2016.10.003","volume":"84","author":"C Blanco","year":"2017","unstructured":"Blanco C, Compton WM, Saha TD, Goldstein BI, Ruan WJ, Huang B, Grant BF. Epidemiology of DSM-5 bipolar I disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III. J Psychiatr Res. 2017;84:310\u20137. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.10.003.","journal-title":"J Psychiatr Res"},{"key":"429_CR82","unstructured":"Blick C, Nguyen M, Jialal I. (2026) Thyrotoxicosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482216\/"},{"key":"429_CR6","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1017\/S2045796021000305","volume":"30","author":"JKN Chan","year":"2021","unstructured":"Chan JKN, Wong CSM, Yung NCL, Chen EYH, Chang WC. Excess mortality and life-years lost in people with bipolar disorder: an 11-year population-based cohort study. Epidemiol psychiatric Sci. 2021;30:e39. https:\/\/doi.org\/10.1017\/S2045796021000305.","journal-title":"Epidemiol psychiatric Sci"},{"issue":"6","key":"429_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1469-7580.2010.01312.x","volume":"217","author":"HM Chang","year":"2010","unstructured":"Chang HM, Mai FD, Lei SL, Ling YC. Impaired sodium levels in the suprachiasmatic nucleus are associated with the formation of cardiovascular deficiency in sleep-deprived rats. J Anat. 2010;217(6):694\u2013704. https:\/\/doi.org\/10.1111\/j.1469-7580.2010.01312.x.","journal-title":"J Anat"},{"issue":"2","key":"429_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/er.2009-0007","volume":"31","author":"SY Cheng","year":"2010","unstructured":"Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31(2):139\u201370. https:\/\/doi.org\/10.1210\/er.2009-0007.","journal-title":"Endocr Rev"},{"issue":"4","key":"429_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archpsyc.1983.01790040068010","volume":"40","author":"RW Cowdry","year":"1983","unstructured":"Cowdry RW, Wehr TA, Zis AP, Goodwin FK. Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch Gen Psychiatry. 1983;40(4):414\u201320. https:\/\/doi.org\/10.1001\/archpsyc.1983.01790040068010.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"429_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1600-0447.1984.tb04513.x","volume":"69","author":"G Dagher","year":"1984","unstructured":"Dagher G, Gay C, Brossard M, Feray JC, Oli\u00e9 JP, Garay RP, Loo H, Meyer P. Lithium, sodium and potassium transport in erythrocytes of manic-depressive patients. Acta psychiatrica Scandinavica. 1984;69(1):24\u201336. https:\/\/doi.org\/10.1111\/j.1600-0447.1984.tb04513.x.","journal-title":"Acta psychiatrica Scandinavica"},{"issue":"2","key":"429_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.59566\/IJBS.2014.10085","volume":"10","author":"GR de Lores Arnaiz","year":"2014","unstructured":"de Lores Arnaiz GR, Ordieres MG. Brain Na(+), K(+)-ATPase activity in aging and disease. Int J biomedical science: IJBS. 2014;10(2):85\u2013102. Brain Na(+), K(+)-ATPase Activity In Aging and Disease - PubMed.","journal-title":"Int J biomedical science: IJBS"},{"issue":"8","key":"429_CR67","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1089\/thy.2011.0029","volume":"21","author":"M Devdhar","year":"2011","unstructured":"Devdhar M, Drooger R, Pehlivanova M, Singh G, Jonklaas J. Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid: official J Am Thyroid Association. 2011;21(8):821\u20137. https:\/\/doi.org\/10.1089\/thy.2011.0029.","journal-title":"Thyroid: official J Am Thyroid Association"},{"issue":"7","key":"429_CR31","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/archpsyc.1989.01810070058010","volume":"46","author":"SL Dubovsky","year":"1989","unstructured":"Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, Baker N, Harris RA. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry. 1989;46(7):632\u20138. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810070058010.","journal-title":"Arch Gen Psychiatry"},{"issue":"3\u20134","key":"429_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cnr.2004.09.014","volume":"4","author":"RS El-Mallakh","year":"2004","unstructured":"El-Mallakh RS. Ion homeostasis and the mechanism of action of lithium. Clin Neurosci Res. 2004;4(3\u20134):227\u201331. https:\/\/doi.org\/10.1016\/j.cnr.2004.09.014.","journal-title":"Clin Neurosci Res"},{"key":"429_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/10673220127873","volume":"9","author":"RS El-Mallakh","year":"2001","unstructured":"El-Mallakh RS, Huff MO. Mood stabilizers and ion regulation. Harv Rev Psychiatry. 2001;9:23\u201332.","journal-title":"Harv Rev Psychiatry"},{"issue":"4","key":"429_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0006-3223(94)00201-D","volume":"37","author":"RS el-Mallakh","year":"1995","unstructured":"el-Mallakh RS, Wyatt RJ. The Na,K-ATPase hypothesis for bipolar illness. Biol Psychiatry. 1995;37(4):235\u201344. https:\/\/doi.org\/10.1016\/0006-3223(94)00201-D.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"429_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0278-5846(95)00123-d","volume":"19","author":"RS el-Mallakh","year":"1995","unstructured":"el-Mallakh RS, Harrison LT, Li R, Changaris DG, Levy RS. An animal model for mania: preliminary results. Prog Neuro-psychopharmacol Biol Psychiatry. 1995;19(5):955\u201362. https:\/\/doi.org\/10.1016\/0278-5846(95)00123-d.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"1","key":"429_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0165-0327(96)00063-8","volume":"41","author":"RS El-Mallakh","year":"1996","unstructured":"El-Mallakh RS, Li R, Worth CA, Peiper SC. Leukocyte transmembrane potential in bipolar illness. J Affect Disord. 1996;41(1):33\u20137. https:\/\/doi.org\/10.1016\/0165-0327(96)00063-8.","journal-title":"J Affect Disord"},{"issue":"1","key":"429_CR36","first-page":"1076","volume":"3","author":"RS El-Mallakh","year":"2016","unstructured":"El-Mallakh RS, Yff T, Gao Y. Ion dysregulation in the pathogenesis of bipolar disorder. Annals Depress Anxiety. 2016;3(1):1076. Ion Dysregulation in the Pathogenesis of Bipolar Illness.","journal-title":"Annals Depress Anxiety"},{"key":"429_CR39","doi-asserted-by":"publisher","first-page":"114399","DOI":"10.1016\/j.psychres.2022.114399","volume":"309","author":"RS El-Mallakh","year":"2022","unstructured":"El-Mallakh RS, Gao Y, Roberts M, Hamlyn J. Sleep deprivation is associated with increased circulating levels of endogenous ouabain: Potential role in bipolar disorder. Psychiatry Res. 2022;309:114399. https:\/\/doi.org\/10.1016\/j.psychres.2022.114399.","journal-title":"Psychiatry Res"},{"issue":"2","key":"429_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/bdi.12737","volume":"21","author":"Y Gao","year":"2019","unstructured":"Gao Y, Lohano K, Delamere NA, Lei Z, El-Mallakh RS. Ethanol normalizes glutamate-induced elevation of intracellular sodium in olfactory neuroepithelial progenitors from subjects with bipolar illness but not nonbipolar controls: Biologic evidence for the self-medication hypothesis. Bipolar Disord. 2019;21(2):179\u201381. https:\/\/doi.org\/10.1111\/bdi.12737.","journal-title":"Bipolar Disord"},{"key":"429_CR35","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1038\/s41598-022-14187-w","volume":"12","author":"Y Gao","year":"2022","unstructured":"Gao Y, Mack AA, Litteral C, et al. NMDA receptor inhibition prevents intracellular sodium elevations in human olfactory neuroepithelial precursors derived from bipolar patients. Sci Rep. 2022a;12:10437. https:\/\/doi.org\/10.1038\/s41598-022-14187-w.","journal-title":"Sci Rep"},{"issue":"1","key":"429_CR46","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1038\/s41598-022-14187-w","volume":"12","author":"Y Gao","year":"2022","unstructured":"Gao Y, Mack AA, Litteral C, Delamere NA, El-Mallakh RS. NMDA receptor inhibition prevents intracellular sodium elevations in human olfactory neuroepithelial precursors derived from bipolar patients. Sci Rep. 2022b;12(1):10437. https:\/\/doi.org\/10.1038\/s41598-022-14187-w.","journal-title":"Sci Rep"},{"issue":"4","key":"429_CR78","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0006-3223(96)00472-6","volume":"41","author":"L Gyulai","year":"1997","unstructured":"Gyulai L, Jaggi J, Bauer MS, Younkin S, Rubin L, Attie M, Whybrow PC. Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder. Biol Psychiatry. 1997;41(4):503\u20136. https:\/\/doi.org\/10.1016\/S0006-3223(96)00472-6.","journal-title":"Biol Psychiatry"},{"issue":"2\u20133","key":"429_CR79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0165-0327(00)00306-2","volume":"66","author":"L Gyulai","year":"2001","unstructured":"Gyulai L, Bauer M, Garcia-Espana F, Hierholzer J, Baumgartner A, Bergh\u00f6fer A, Whybrow PC. Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation. J Affect Disord. 2001;66(2\u20133):185\u201391. https:\/\/doi.org\/10.1016\/s0165-0327(00)00306-2.","journal-title":"J Affect Disord"},{"issue":"6","key":"429_CR56","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.neubiorev.2007.04.001","volume":"31","author":"L Herman","year":"2007","unstructured":"Herman L, Hougland T, El-Mallakh RS. Mimicking human bipolar ion dysregulation models mania in rats. Neurosci Biobehav Rev. 2007;31(6):874\u201381. https:\/\/doi.org\/10.1016\/j.neubiorev.2007.04.001.","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"429_CR37","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1038\/s41380-023-02152-6","volume":"28","author":"T Hewitt","year":"2023","unstructured":"Hewitt T, Alural B, Tilak M, Wang J, Becke N, Chartley E, Perreault M, Haggarty SJ, Sheridan SD, Perlis RH, Jones N, Mellios N, Lalonde J. Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca2\u2009+\u2009entry and accelerated differentiation. Mol Psychiatry. 2023;28(12):5237\u201350. https:\/\/doi.org\/10.1038\/s41380-023-02152-6.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"429_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pnpbp.2008.11.014","volume":"33","author":"T Hosokawa","year":"2009","unstructured":"Hosokawa T, Momose T, Kasai K. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Prog Neuro-psychopharmacol Biol Psychiatry. 2009;33(2):243\u201350. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.11.014.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"8","key":"429_CR88","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.4088\/jcp.v66n0812","volume":"66","author":"DV Iosifescu","year":"2005","unstructured":"Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry. 2005;66(8):1038\u201342. https:\/\/doi.org\/10.4088\/jcp.v66n0812.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"429_CR25","first-page":"44","volume":"12","author":"F Ismail-Beigi","year":"1992","unstructured":"Ismail-Beigi F. Regulation of Na+,K(+)-ATPase expression by thyroid hormone. Semin Nephrol. 1992;12(1):44\u20138.","journal-title":"Semin Nephrol"},{"key":"429_CR66","doi-asserted-by":"publisher","unstructured":"Jonklaas J. (2010). Sex and age differences in levothyroxine dosage requirement. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 16(1), 71\u201379. https:\/\/doi.org\/10.4158\/EP09257.OR","DOI":"10.4158\/EP09257.OR"},{"issue":"1","key":"429_CR87","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/FTD.0000000000000113","volume":"37","author":"J Jonklaas","year":"2015","unstructured":"Jonklaas J, Burman KD, Wang H, Latham KR. Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters. Ther Drug Monit. 2015;37(1):110\u20138. https:\/\/doi.org\/10.1097\/FTD.0000000000000113.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"429_CR69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/brainsci13010133","volume":"13","author":"B Joseph","year":"2023","unstructured":"Joseph B, Nunez NA, Pazdernik V, Kumar R, Pahwa M, Ercis M, Ozerdem A, Cuellar-Barboza AB, Romo-Nava F, McElroy SL, Coombes BJ, Biernacka JM, Stan MN, Frye MA, Singh B. Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study. Brain Sci. 2023;13(1):133. https:\/\/doi.org\/10.3390\/brainsci13010133.","journal-title":"Brain Sci"},{"issue":"2","key":"429_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S1461145703003341","volume":"6","author":"LL Judd","year":"2003","unstructured":"Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, Endicott J, Keller M. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol. 2003;6(2):127\u201337. https:\/\/doi.org\/10.1017\/S1461145703003341.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"429_CR77","doi-asserted-by":"publisher","first-page":"bvab194","DOI":"10.1210\/jendso\/bvab194","volume":"6","author":"M Jurado-Flores","year":"2022","unstructured":"Jurado-Flores M, Warda F, Mooradian A. Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease. J Endocr Soc. 2022;6(2):bvab194. https:\/\/doi.org\/10.1210\/jendso\/bvab194.","journal-title":"J Endocr Soc"},{"issue":"1\u20132","key":"429_CR90","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.0954-6820.1978.tb08394.x","volume":"204","author":"G Kallner","year":"1978","unstructured":"Kallner G, Ljunggren JG, Tryselius M. The effect of propranolol on serum levels of T4, T3 and reverse-T3 in hyperthyroidism. Acta Med Scand. 1978;204(1\u20132):35\u20137. https:\/\/doi.org\/10.1111\/j.0954-6820.1978.tb08394.x.","journal-title":"Acta Med Scand"},{"key":"429_CR80","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jad.2014.04.022","volume":"166","author":"T Kelly","year":"2014","unstructured":"Kelly T. A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis. J Affect Disord. 2014;166:353\u20138. https:\/\/doi.org\/10.1016\/j.jad.2014.04.022.","journal-title":"J Affect Disord"},{"key":"429_CR84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jad.2015.01.016","volume":"177","author":"T Kelly","year":"2015","unstructured":"Kelly T. An examination of myth: a favorable cardiovascular risk-benefit analysis of high-dose thyroid for affective disorders. J Affect Disord. 2015;177:49\u201358. https:\/\/doi.org\/10.1016\/j.jad.2015.01.016.","journal-title":"J Affect Disord"},{"key":"429_CR76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mehy.2016.09.022","volume":"97","author":"T Kelly","year":"2016","unstructured":"Kelly T. A hypothesis on the mechanism of action of high-dose thyroid in refractory mood disorders. Med Hypotheses. 2016;97:16\u201321. https:\/\/pubmed.ncbi.nlm.nih.gov\/27876122\/.","journal-title":"Med Hypotheses"},{"issue":"3","key":"429_CR61","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jad.2008.12.010","volume":"116","author":"T Kelly","year":"2009","unstructured":"Kelly T, Lieberman DZ. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS. J Affect Disord. 2009;116(3):222\u20136. https:\/\/doi.org\/10.1016\/j.jad.2008.12.010.","journal-title":"J Affect Disord"},{"key":"429_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2016.06.001","volume":"71","author":"T Kelly","year":"2016","unstructured":"Kelly T, Denmark L, Lieberman DZ. Elevated levels of circulating thyroid hormone do not cause the medical sequelae of hyperthyroidism. Prog Neuro-psychopharmacol Biol Psychiatry. 2016;71:1\u20136. https:\/\/doi.org\/10.1016\/j.pnpbp.2016.06.001.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"1","key":"429_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajp.2012.08.003","volume":"6","author":"VN Krishna","year":"2013","unstructured":"Krishna VN, Thunga R, Unnikrishnan B, Kanchan T, Bukelo MJ, Mehta RK, Venugopal A. Association between bipolar affective disorder and thyroid dysfunction. Asian J psychiatry. 2013;6(1):42\u20135. https:\/\/doi.org\/10.1016\/j.ajp.2012.08.003.","journal-title":"Asian J psychiatry"},{"issue":"4","key":"429_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s0006-3223(01)01217-3","volume":"51","author":"RW Kupka","year":"2002","unstructured":"Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, Frye MA, Keck PE Jr, Leverich GS, Rush AJ, Suppes T, Pollio C, Drexhage HA. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry. 2002;51(4):305\u201311. https:\/\/doi.org\/10.1016\/s0006-3223(01)01217-3.","journal-title":"Biol Psychiatry"},{"issue":"1\u20133","key":"429_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2011.06.008","volume":"131","author":"TM Laursen","year":"2011","unstructured":"Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011;131(1\u20133):101\u20134. https:\/\/doi.org\/10.1016\/j.schres.2011.06.008.","journal-title":"Schizophr Res"},{"issue":"10","key":"429_CR71","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1089\/thy.1998.8.909","volume":"8","author":"JH Lazarus","year":"1998","unstructured":"Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid: official J Am Thyroid Association. 1998;8(10):909\u201313. https:\/\/doi.org\/10.1089\/thy.1998.8.909.","journal-title":"Thyroid: official J Am Thyroid Association"},{"key":"429_CR68","doi-asserted-by":"publisher","unstructured":"Lazarus JH. (2009). Lithium and thyroid. Best practice & research. Clinical endocrinology & metabolism, 23(6), 723\u2013733. https:\/\/doi.org\/10.1016\/j.beem.2009.06.002","DOI":"10.1016\/j.beem.2009.06.002"},{"issue":"3","key":"429_CR27","doi-asserted-by":"publisher","first-page":"L762","DOI":"10.1152\/ajplung.00376.2002","volume":"285","author":"J Lei","year":"2003","unstructured":"Lei J, Nowbar S, Mariash CN, Ingbar DH. Thyroid hormone stimulates Na-K-ATPase activity and its plasma membrane insertion in rat alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;285(3):L762\u201372. https:\/\/doi.org\/10.1152\/ajplung.00376.2002.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"429_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0165-0327(03)00044-2","volume":"80","author":"R Li","year":"2004","unstructured":"Li R, El-Mallakh RS. Differential response of bipolar and normal control lymphoblastoid cell sodium pump to ethacrynic acid. J Affect Disord. 2004;80:11\u20137.","journal-title":"J Affect Disord"},{"key":"429_CR75","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2147\/NDT.S196661","volume":"15","author":"C Li","year":"2019","unstructured":"Li C, Lai J, Huang T, Han Y, Du Y, Xu Y, Hu S. Thyroid functions in patients with bipolar disorder and the impact of quetiapine monotherapy: a retrospective, naturalistic study. Neuropsychiatr Dis Treat. 2019;15:2285\u201390. https:\/\/doi.org\/10.2147\/NDT.S196661.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"429_CR1","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3390\/ijms19082314","volume":"19","author":"D Lichtstein","year":"2018","unstructured":"Lichtstein D, Ilani A, Rosen H, Horesh N, Singh SV, Buzaglo N, Hodes A. Na\u207a, K\u207a-ATPase Signaling and Bipolar Disorder. Int J Mol Sci. 2018;19(8):2314. https:\/\/doi.org\/10.3390\/ijms19082314.","journal-title":"Int J Mol Sci"},{"key":"429_CR86","doi-asserted-by":"crossref","unstructured":"Lipp HP, Administration, and Pharmacokinetics of Levothyroxine. 2021 Mar 12. In: Kahaly GJ, editor. 70 Years of Levothyroxine [Internet]. Cham (CH): Springer; 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585644\/","DOI":"10.1007\/978-3-030-63277-9_2"},{"issue":"2","key":"429_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1520-6394(1997)5:2<53::AID-DA1>3.0.CO;2-6","volume":"5","author":"SW Looney","year":"1997","unstructured":"Looney SW, El-Mallakh RS. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depress Anxiety. 1997;5(2):53\u201365. https:\/\/pubmed.ncbi.nlm.nih.gov\/9262935\/.","journal-title":"Depress Anxiety"},{"key":"429_CR54","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neubiorev.2019.09.016","volume":"107","author":"AA Mack","year":"2019","unstructured":"Mack AA, Gao Y, Ratajczak MZ, Kakar S, El-Mallakh RS. Review of animal models of bipolar disorder that alter ion regulation. Neurosci Biobehav Rev. 2019;107:208\u201314. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.016.","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"429_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1399-5618.2009.00762.x","volume":"11","author":"L Mann","year":"2009","unstructured":"Mann L, Heldman E, Bersudsky Y, Vatner SF, Ishikawa Y, Almog O, Belmaker RH, Agam G. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect. Bipolar Disord. 2009;11(8):885\u201396. https:\/\/doi.org\/10.1111\/j.1399-5618.2009.00762.x.","journal-title":"Bipolar Disord"},{"issue":"7576","key":"429_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature15526","volume":"527","author":"J Mertens","year":"2015","unstructured":"Mertens J, Wang QW, Kim Y, Yu DX, Pham S, Yang B, Zheng Y, Diffenderfer KE, Zhang J, Soltani S, Eames T, Schafer ST, Boyer L, Marchetto MC, Nurnberger JI, Calabrese JR, \u00d8degaard KJ, McCarthy MJ, Zandi PP, Alda M, Yao J. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015;527(7576):95\u20139. https:\/\/doi.org\/10.1038\/nature15526.","journal-title":"Nature"},{"key":"429_CR26","doi-asserted-by":"publisher","first-page":"e81645","DOI":"10.7554\/eLife.81645","volume":"11","author":"DJ Meyer","year":"2022","unstructured":"Meyer DJ, D\u00edaz-Garc\u00eda CM, Nathwani N, Rahman M, Yellen G. The Na+\/K+ pump dominates control of glycolysis in hippocampal dentate granule cells. eLife. 2022;11:e81645. https:\/\/doi.org\/10.7554\/eLife.81645.","journal-title":"eLife"},{"issue":"3","key":"429_CR72","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1210\/endo-124-3-1365","volume":"124","author":"M Mori","year":"1989","unstructured":"Mori M, Tajima K, Oda Y, Matsui I, Mashita K, Tarui S. Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system. Endocrinology. 1989;124(3):1365\u20139. https:\/\/doi.org\/10.1210\/endo-124-3-1365.","journal-title":"Endocrinology"},{"key":"429_CR20","unstructured":"National Center for Biotechnology Information. (2022). Thyroid Hormone Synthesis. In: StatPearls. Treasure Island (FL): StatPearls Publishing. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500006\/"},{"key":"429_CR19","unstructured":"National Center for Biotechnology Information. (2018). PubChem Compound Summary for CID 6068, Cyclic AMP. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Cyclic-AMP"},{"issue":"2","key":"429_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0022-3999(70)90027-9","volume":"14","author":"GJ Naylor","year":"1970","unstructured":"Naylor GJ, McNamee HB, Moody JP. Erythrocyte sodium and potassium in depressive illness. J Psychosom Res. 1970;14(2):173\u20137. https:\/\/doi.org\/10.1016\/0022-3999(70)90027-9.","journal-title":"J Psychosom Res"},{"issue":"14","key":"429_CR7","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/jama.2023.18588","volume":"330","author":"AA Nierenberg","year":"2023","unstructured":"Nierenberg AA, Agustini B, K\u00f6hler-Forsberg O, Cusin C, Katz D, Sylvia LG, Peters A, Berk M. Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA. 2023;330(14):1370\u201380. https:\/\/doi.org\/10.1001\/jama.2023.18588.","journal-title":"JAMA"},{"key":"429_CR83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jad.2018.05.034","volume":"238","author":"M Pilhatsch","year":"2018","unstructured":"Pilhatsch M, Bergh\u00f6fer A, Mayer-Pelinski R, Bergh\u00f6fer G, Ricken R, M\u00f6ckel M, K\u00fchnle Y, Sauer C, Whybrow PC, Bauer M. Long-term treatment with supraphysiologic doses of levothyroxine in treatment-refractory mood disorders - A prospective study of cardiovascular tolerability. J Affect Disord. 2018;238:213\u20137. https:\/\/doi.org\/10.1016\/j.jad.2018.05.034.","journal-title":"J Affect Disord"},{"issue":"6","key":"429_CR70","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archpsyc.1991.01810300025004","volume":"48","author":"ED Risby","year":"1991","unstructured":"Risby ED, Hsiao JK, Manji HK, Bitran J, Moses F, Zhou DF, Potter WZ. The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects. Arch Gen Psychiatry. 1991;48(6):513\u201324. https:\/\/doi.org\/10.1001\/archpsyc.1991.01810300025004.","journal-title":"Arch Gen Psychiatry"},{"issue":"2 Pt 2","key":"429_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/15622970902718774","volume":"11","author":"RJ Roberts","year":"2010","unstructured":"Roberts RJ, Repass R, El-Mallakh RS. Effect of dopamine on intracellular sodium: a common pathway for pharmacological mechanism of action in bipolar illness. world J Biol psychiatry: official J World Federation Soc Biol Psychiatry. 2010;11(2 Pt 2):181\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/19396728\/.","journal-title":"world J Biol psychiatry: official J World Federation Soc Biol Psychiatry"},{"issue":"9","key":"429_CR50","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/s0006-3223(97)00440-x","volume":"44","author":"AM Rose","year":"1998","unstructured":"Rose AM, Mellett BJ, Valdes R Jr, Kleinman JE, Herman MM, Li R, el-Mallakh RS. Alpha 2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry. 1998;44(9):892\u20137. https:\/\/doi.org\/10.1016\/s0006-3223(97)00440-x.","journal-title":"Biol Psychiatry"},{"issue":"10","key":"429_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1176\/appi.ajp.2011.10030402","volume":"168","author":"LJ Rosenthal","year":"2011","unstructured":"Rosenthal LJ, Goldner WS, O\u2019Reardon JP. T3 augmentation in major depressive disorder: safety considerations. Am J Psychiatry. 2011;168(10):1035\u201340. https:\/\/doi.org\/10.1176\/appi.ajp.2011.10030402.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"429_CR55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41398-025-03529-7","volume":"15","author":"ESE Sabbagh","year":"2025","unstructured":"Sabbagh ESE, Kolinski Machado D, Pappis A, Leigh Beroncal L, Ji E, Nader D, Ravi Chander G, Choi P, Duong J, Jeong A, Panizzutti H, Bortolasci B, Szatmari CC, Carlen A, Hahn P, Attisano M, Berk L, Walder M, K., Andreazza AC. iPSC-derived cerebral organoids reveal mitochondrial, inflammatory and neuronal vulnerabilities in bipolar disorder. Translational psychiatry. 2025;15(1):315. https:\/\/doi.org\/10.1038\/s41398-025-03529-7.","journal-title":"Translational psychiatry"},{"issue":"11","key":"429_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/brainsci12111540","volume":"12","author":"A Seshadri","year":"2022","unstructured":"Seshadri A, Sundaresh V, Prokop LJ, Singh B. Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review. Brain Sci. 2022;12(11):1540. https:\/\/doi.org\/10.3390\/brainsci12111540.","journal-title":"Brain Sci"},{"issue":"2","key":"429_CR63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4088\/JCP.12m08305","volume":"75","author":"TJ Stamm","year":"2014","unstructured":"Stamm TJ, Lewitzka U, Sauer C, Pilhatsch M, Smolka MN, Koeberle U, Adli M, Ricken R, Scherk H, Frye MA, Juckel G, Assion HJ, Gitlin M, Whybrow PC, Bauer M. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2014;75(2):162\u20138. https:\/\/doi.org\/10.4088\/JCP.12m08305.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"429_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/archpsyc.1982.04290030045008","volume":"39","author":"HC Stancer","year":"1982","unstructured":"Stancer HC, Persad E. Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Clinical observations. Arch Gen Psychiatry. 1982;39(3):311\u20132. https:\/\/doi.org\/10.1001\/archpsyc.1982.04290030045008.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"429_CR9","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.18502\/ijph.v51i8.10264","volume":"51","author":"G Stani\u0107","year":"2022","unstructured":"Stani\u0107 G, Sne\u017eana M, Ignjatovi\u0107 DR. Influence of Thyroid Disorders upon the Incidence and the Severity of Psychosomatic Symptoms in Patients. Iran J public health. 2022;51(8):1798\u2013806. https:\/\/doi.org\/10.18502\/ijph.v51i8.10264.","journal-title":"Iran J public health"},{"key":"429_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2018.10.360","volume":"245","author":"L Steardo Jr","year":"2019","unstructured":"Steardo L Jr, Fabrazzo M, Sampogna G, Monteleone AM, D\u2019Agostino G, Monteleone P, Maj M. Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments. J Affect Disord. 2019;245:174\u20139. https:\/\/doi.org\/10.1016\/j.jad.2018.10.360.","journal-title":"J Affect Disord"},{"issue":"2","key":"429_CR38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biopsych.2020.01.020","volume":"88","author":"S Stern","year":"2020","unstructured":"Stern S, Sarkar A, Galor D, Stern T, Mei A, Stern Y, Mendes APD, Randolph-Moore L, Rouleau G, Bang AG, Santos R, Alda M, Marchetto MC, Gage FH. A Physiological Instability Displayed in Hippocampal Neurons Derived From Lithium-Nonresponsive Bipolar Disorder Patients. Biol Psychiatry. 2020;88(2):150\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2020.01.020.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"429_CR28","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.3390\/ijms23084133","volume":"23","author":"SM Sundaram","year":"2022","unstructured":"Sundaram SM, Marx R, Lesslich HM, Dietzel ID. Deficiency of Thyroid Hormone Reduces Voltage-Gated Na+ Currents as Well as Expression of Na+\/K+-ATPase in the Mouse Hippocampus. Int J Mol Sci. 2022;23(8):4133. https:\/\/doi.org\/10.3390\/ijms23084133.","journal-title":"Int J Mol Sci"},{"key":"429_CR74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpsychires.2018.09.014","volume":"106","author":"TSJ Vedal","year":"2018","unstructured":"Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, R\u00f8devand L, Melle I, Andreassen OA, Molden E, J\u00f6nsson EG. Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication. J Psychiatr Res. 2018;106:74\u201381. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.09.014.","journal-title":"J Psychiatr Res"},{"issue":"7","key":"429_CR62","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/bdi.12657","volume":"20","author":"PD Walshaw","year":"2018","unstructured":"Walshaw PD, Gyulai L, Bauer M, Bauer MS, Calimlim B, Sugar CA, Whybrow PC. Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: A double-blind placebo-controlled trial of levothyroxine (L-T4) and triiodothyronine (T3). Bipolar Disord. 2018;20(7):594\u2013603. https:\/\/doi.org\/10.1111\/bdi.12657.","journal-title":"Bipolar Disord"},{"key":"429_CR51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1192\/bjp.137.4.343","volume":"137","author":"LJ Whalley","year":"1980","unstructured":"Whalley LJ, Scott M, Reading HW, Christie JE. Effect of electroconvulsive therapy on erythrocyte adenosine triphosphatase activity in depressive illness. Br J psychiatry: J mental Sci. 1980;137:343\u20135. https:\/\/doi.org\/10.1192\/bjp.137.4.343.","journal-title":"Br J psychiatry: J mental Sci"},{"issue":"3","key":"429_CR89","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/thy.1991.1.273","volume":"1","author":"WM Wiersinga","year":"1991","unstructured":"Wiersinga WM. Propranolol and thyroid hormone metabolism. Thyroid: official J Am Thyroid Association. 1991;1(3):273\u20137. https:\/\/doi.org\/10.1089\/thy.1991.1.273.","journal-title":"Thyroid: official J Am Thyroid Association"},{"key":"429_CR3","unstructured":"World Health Organization. Bipolar Disorder. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/bipolar-disorder 5 September 2025."},{"issue":"19","key":"429_CR8","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.3390\/jcm11195830","volume":"11","author":"AC Zamar","year":"2022","unstructured":"Zamar AC, Kouimtsidis C, Lulsegged A, Roberts R, Koutsomitros T, Stahl D. A New Treatment Protocol of Combined High-Dose Levothyroxine and Repetitive Transcranial Magnetic Stimulation for the Treatment of Rapid-Cycling Bipolar Spectrum Disorders: A Cohort Evaluation of 55 Patients. J Clin Med. 2022;11(19):5830. https:\/\/doi.org\/10.3390\/jcm11195830.","journal-title":"J Clin Med"}],"container-title":["International Journal of Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40345-026-00429-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-026-00429-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-026-00429-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:04:02Z","timestamp":1786543442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40345-026-00429-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1186\/s40345-026-00429-7","relation":{},"ISSN":["2194-7511"],"issn-type":[{"value":"2194-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a narrative review of previously published literature and did not involve human participants, animals, or identifiable personal data.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. El-Mallakh is a speaker for Axsome, Johnson and Johnson, Lundbeck, Otsuka, and Vanda. None of the other authors have any potential conflicts to declare.","order":2,"name":"Ethics","label":"Potential conflicts","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30"}}